DNA profile and tumour progression in patients with superficial bladder tumours - PubMed (original) (raw)

• PMID: 7072022
• DOI: 10.1007/BF00256518

DNA profile and tumour progression in patients with superficial bladder tumours

H Gustafson et al. Urol Res. 1982 Feb.

Abstract

229 patients with Grade 1-2 tumours (WHO), all category Ta or T1 (UICC) and surgically treated, were followed clinically and by flowcytofluorometric DNA-analysis (FCM). The tumours were characterised by their DNA profile. 175 cases were found to be diploid and fifty-four cases showed aneuploidy. The mean follow-up time with continuous FCM analysis was 2.6 years. During this period 19 patients showed tumour progression and 11 of these patients died. No progressive cases were found among 175 patients with repeatedly diploid DNA patterns. Thus tumour progression was exclusively linked to an aneuploid DNA pattern. In these case the degree of ploidy determined the frequency of progression: while 50% of the cases with triploid--hypotetraploid DNA pattern showed progression, only 10% of tumours with a tetraploid amount of DNA were found to be progressive. The degree of ploidy in 33 cases with recurrent aneuploid tumours was in general found to be constant. A fairly high degree of consistency was also found in the number of cells in S-phase, expressing proliferative properties. This indicates that superficial bladder tumours can be well characterised by their DNA profiles, that is the degree of ploidy and the proliferation pattern.

PubMed Disclaimer

Similar articles

• The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumours: a study of 100 untreated cases.
  Tribukait B, Gustafson H, Esposti PL. Tribukait B, et al. Br J Urol. 1982 Apr;54(2):130-5. doi: 10.1111/j.1464-410x.1982.tb13536.x. Br J Urol. 1982. PMID: 7082931
• DNA pattern, histological grade and multiplicity related to recurrence rate in superficial bladder tumours.
  Gustafson H, Tribukait B, Esposti PL. Gustafson H, et al. Scand J Urol Nephrol. 1982;16(2):135-9. doi: 10.3109/00365598209179742. Scand J Urol Nephrol. 1982. PMID: 7123163
• Characterization of bladder carcinomas by flow DNA analysis.
  Gustafson H, Tribukait B. Gustafson H, et al. Eur Urol. 1985;11(6):410-7. doi: 10.1159/000472552. Eur Urol. 1985. PMID: 4085533
• [DNA ploidy pattern of flow cytometry as indicator of malignancy and prognosis in bladder cancer].
  Hosaka Y. Hosaka Y. Nihon Rinsho. 1992 Oct;50(10):2426-31. Nihon Rinsho. 1992. PMID: 1447813 Review. Japanese.
• [Role of pathologic anatomy in the diagnosis, prognostic evaluation, and surveillance of bladder tumors].
  Zérat L, Guiu M, Vorhauer W. Zérat L, et al. Prog Urol. 1992 Dec;2(6):1045-59. Prog Urol. 1992. PMID: 1302128 Review. French.

Cited by

• Proliferative pattern of urothelial bladder cancer and urothelial atypias.
  Helpap B, Schwabe HW, Adolphs HD. Helpap B, et al. J Cancer Res Clin Oncol. 1985;109(1):46-54. doi: 10.1007/BF01884254. J Cancer Res Clin Oncol. 1985. PMID: 3972885
• The clinical value of urinary cytology: 12 years of experience with 615 patients.
  Maier U, Simak R, Neuhold N. Maier U, et al. J Clin Pathol. 1995 Apr;48(4):314-7. doi: 10.1136/jcp.48.4.314. J Clin Pathol. 1995. PMID: 7615848 Free PMC article.
• Clinical DNA flow cytometry.
  Tribukait B. Tribukait B. Med Oncol Tumor Pharmacother. 1984;1(4):211-8. doi: 10.1007/BF02934525. Med Oncol Tumor Pharmacother. 1984. PMID: 6544901
• Retrospective study of prognostic importance of DNA flow cytometry of urinary bladder carcinoma.
  Blomjous CE, Schipper NW, Baak JP, van Galen EM, de Voogt HJ, Meyer CJ. Blomjous CE, et al. J Clin Pathol. 1988 Jan;41(1):21-5. doi: 10.1136/jcp.41.1.21. J Clin Pathol. 1988. PMID: 3343376 Free PMC article.
• Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables.
  Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ. Rabinovitch PS, et al. Am J Gastroenterol. 2001 Nov;96(11):3071-83. doi: 10.1111/j.1572-0241.2001.05261.x. Am J Gastroenterol. 2001. PMID: 11721752 Free PMC article.

References

1. 1. Acta Chir Scand. 1965 Oct;130(4):371-8 - PubMed
2. 1. Onkologie. 1980 Dec;3(6):278-88 - PubMed
3. 1. Br J Urol. 1982 Apr;54(2):130-5 - PubMed
4. 1. Urol Res. 1978;6(4):201-5 - PubMed
5. 1. J Urol. 1976 Nov;116(5):575-80 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information